Read the latest news from Health. Watch out for current health warnings. And find out how you can have your say on issues that affect you.
Advice on the presence of natural rubber latex in the sheath covering the needle of the Fluad trivalent influenza vaccine. Anyone who has a severe allergy to latex should not receive Fluad.
The Zostavax® vaccine is now available nationally for immunisation providers for people aged 70 to 79 years under the National Immunisation Program (NIP).
The Australian Technical Advisory Group on Immunisation (ATAGI) has provided advice regarding alternatives during supply shortage of the adult formulations of hepatitis B vaccines.
The Australian Technical Advisory Group on Immunisation (ATAGI) has developed advice for immunisation providers regarding the administration of 2018 seasonal influenza vaccines.
The Australian Technical Advisory Group on Immunisation is consulting with stakeholders on proposed changes to meningococcal and Haemophilus influenzae type B vaccination recommendations for inclusion in the Australian Immunisation Handbook.
The Department has developed a template which provides a checklist for immunisation providers to consider before vaccinating a patient with Zostavax (pre-vaccination checklist).
The Australian Technical Advisory Group on Immunisation (ATAGI) has new advice to support school based immunisation providers with the introduction of Gardasil®9 in a 2-dose schedule from January 2018.
From 16 August 2017, general practitioners (GPs), paediatricians, infectious disease physicians, public health physicians and clinical immunologists can issue a medical exemption to vaccination that will be recognised by the Australian Immunisation Register (AIR).
New access arrangements under the National Immunisation Program (NIP) to provide free catch-up vaccines for all individuals aged 10 to 19 years, and refugees and humanitarian entrants aged 20 years and over from 1 July 2017.
Australian Technical Advisory Group on Immunisation (ATAGI) clinical advice to support the introduction of Rotarix® to replace RotaTeq® in specified Australian states (Western Australia, South Australia, Victoria and Queensland) from 1 July 2017.